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KEY POINTS
 Chromoendoscopy increases dysplasia detection in ulcerative colitis, and can be imple-
mented across solo and group practices.
 Chromoendoscopy may not increase procedure time if the practice of random surveil-
lance biopsies is abandoned.INTRODUCTION
Image-enhanced colonoscopy using chromoendoscopy (CE) with targeted biopsy has
been shown to significantly improve dysplasia detection in inflammatory bowel dis-
ease (IBD) colitis. However, the more commonly practiced method for dysplasia
detection in ulcerative colitis (UC) and Crohn’s colitis in the United States has histor-
ically included the low-yielding process of multiple randomly obtained mucosal
biopsies.1–3 White-light colonoscopy alone, without the aid of enhanced imaging or
detailed inspection, is imperfect and lacks acceptable sensitivity and specificity,4,5
with the yield of random biopsy for dysplasia ranging from 0% to 0.2%.6–9
Dysplasia detection rates are significantly higher with CE,7,10 such that CE with tar-
geted biopsy is now recommended.1,2 Adopting the technique into clinical practiceDisclosure Statement: The authors have nothing to disclose.
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Leong et al420has been perceived to be difficult because of availability, lack of endoscopist experi-
ence, reliability of image interpretation, cost, and the additional time needed to
perform the procedure. This article reviews the commonly available technique of
CE. From our own experience and study, suggestions are provided of the key steps
for the implementation of CE into solo and group clinical practices for UC dysplasia
surveillance.
CE
The Technique
CE involves the application of dye solutions (indigo carmine or methylene blue) onto
the colonic mucosa to enhance contrast during surveillance colonoscopy.11 Studies
showing significantly higher yield of dysplasia detection using CE compared with
white-light colonoscopy have used both dyes, with concentrations range from
0.03% to 0.4% for adequate mucosal enhancement. Indigo carmine is a plant-
based dye that pools into the mucosal crevices and can subsequently be washed
away. Methylene blue is a vital dye that is actively taken up by the colonic epithelium
after approximately 60 seconds.11 It has been associated with DNA damage of unclear
clinical significance.12
Adequate colonic preparation quality is essential when using CE. As such, during
colonoscope insertion, irrigate the colon using water and simethicone, and suction
any remaining debris. The washing of residue during intubation thoroughly cleans
the mucosa before the application of CE, and in turn improves the overall efficiency
of the procedure. Once the cecum is reached and the mucosa is cleaned, exchange
the water irrigation bottle for the dye solution, and initiate dye spraying. The diluted
dye can then be sprayed onto the mucosa using a standard flushing pump attached
to the scope, either through pressing a foot pedal or a programmed button on the
endoscope handle (Fig. 1). Direct the spray to the antigravity side of the colon in order
to optimize the dye application to all of the colonic mucosa in an efficient manner.
Other studies and practices use a spray catheter for dye application, whereby theFig. 1. Methods of application of CE. (A) Flushing pump with diluted CE solution in the irri-
gation bottle, and use of foot pump (inset). (B) CE spray onto colonic mucosa from the water
channel can be seen during withdrawal. (C) During withdrawal, using CE, a nonpolypoid
lesion is identified. (D) Preparation of diluted CE solution and transfer to syringes for spray
catheter application. (E) Spray catheter is placed into the lumen and the CE solution is
sprayed onto the mucosa during withdrawal (F).
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the assistant continuously sprays the dye through the catheter using a 60-mL syringe
while the endoscopist withdrawals the endoscope. The most recent descriptions and
studies on CE using the flushing pump have shown it to be an efficient method of dye
application because it eliminates the cost of the spray catheter as well as dependency
on the assistant’s spray catheter technique.
IMPLEMENTATION INTO PRACTICE
The implementation of CE with targeted biopsy for surveillance of dysplasia in patients
with IBD requires emphasis on standardization of procedure, quality assurance, and
training (Table 1).
Quality
The adoption of CE for UC dysplasia surveillance across solo and group practices
requires the implementation of quality standards. Although the procedure is simple,
its adequate performance requires acceptable dysplasia detection and procedure
duration. Standardized procedures and reporting allow determination of minimal stan-
dards and the effect of CE on the development of colorectal cancer in UC. A transition
period of combining targeted and random biopsy may be considered before abandon-
ing random surveillance biopsies. Furthermore, it may be appropriate to identify 1 or a
few endoscopists within a practice to perform the technique based on procedure vol-
ume, because outcomes may be improved with high volume.
In our study of 3 academic sites, we implemented the practice of CE for surveillance
colonoscopy in patients with IBD initially through a research protocol.13 We selected 6
gastroenterologists, who were not experts in IBD endoscopy, to participate. They
reviewed the literature along with video examples as well as the practice protocol.
Together, a pair of the participating endoscopists performed the initial procedures
to review the technique and refine the protocol. There was eventual agreement on
the CE technique using indigo carmine through the flushing pump. There was also
agreement that any identified large lesion or one that would be technically difficulty
to remove would be referred to an endoscopic resection expert within their group.
We centrally recorded the procedure information.
Training
The issue of training is important. The American Gastroenterological Association rec-
ommends CE with targeted biopsy, provided that there is expertise available. How-
ever, CE is not taught during fellowship and there has never been by any effort to
train. Therefore, in practice, CE is not performed in the United States. How should
clinicians train when there is no trainer?
Familiarity with the detection of the nonpolypoid colorectal neoplasms is a prereq-
uisite. The nonpolypoid neoplasms have been recognized in the United States only
since 2008; again, most endoscopists did not have the opportunity to learn about
detection, diagnosis, and treatment during fellowship. Given of the paucity of trainers,
we suggest self-learning. Several learning videos are available, particularly through the
American Society for Gastrointestinal Endoscopy (ASGE) Online Learning Library.
Start by learning the detection of nonpolypoid neoplasms in patients who do not
have IBD, as well as learning image-enhanced endoscopy. A training video on the
use of CE with targeted biopsy is now available through the ASGE Online Learning Li-
brary. The published descriptions of the nonpolypoid colorectal neoplasms in colitic
IBD can also provide printed guidance and an atlas for these efforts.
Table 1
Suggested steps for the implementation of CE into endoscopic practice
Equipment
Colonoscope High-definition colonoscope, monitor, and cables
Accessories Apply chromoendoscopy via:
Standard water pump attached to the endoscope activated via foot pedal
Or:
Dye-spray catheter
 Length: 240 cm
 Endoscope accessory channel: 2.8 mm
Single-use spray catheters:
 Olympus model PW-205V or Cook Medical Glo-Tip (GT-7-SPRAY)
 Cost: AU$100–171 per catheter
Reusable spray catheters:
 Olympus model PW-5V-1
 Cost: AU$200 per catheter
Contrast agent Indigo carmine (Sigma-Aldrich)
 Cost: AU$37.80 per vial
 Dilution: 0.5% (topical application)
 For application via the foot pump, mix 2 vials of indigo carmine with
250 mL water (0.03%)
Methylene blue (50 mg in 5 mL, Phebra)
 Storage: <25C
 Cost: AU$36.00 per vial
 Dilution: 0.1% (topical application)
Procedure and Protocol
Time allotment Consider initially during the learning curve period double colonoscopy
time slot. Procedure times for CE have included random biopsies
Standard
operating
procedure
Complete colonoscopy to cecum
 Lavage with water and suction during intubation
Prepare contrast solution during insertion for application via the foot
pump or spray
 Indigo carmine: mix 2 vials of indigo carmine with 250 mL water (0.03%)
 Indigo carmine: mix to indigo carmine with 1000cc water to obtain a
concentration of 0.1 to 0.4%
If using a foot pump: once the cecum is intubated, the water irrigation can
be exchanged with the contrast solution. Apply the CE in a
circumferential technique withdrawing the colonoscope
If using a spray catheter: the dye-spray catheter is inserted into the
working channel; the catheter tip should protrude 2–3 cm from the
endoscope
 Apply catheter dye solution segmentally using a rotational technique,
withdrawing the colonoscope at the same time to cover the surface
mucosa with dye
Suction any excess solution after approximately 1 min to aid mucosal
visualization
 Focus on segments of 20–30 cm sequentially with reinsertion of the
endoscope to the proximal extent of each segment before slow with-
drawal and mucosal visualization
Remove endoscopically resectable suspicious lesions using polypectomy or
EMR
Take targeted biopsies of any nonresectable abnormality visualized
through CE to diagnose dysplasia
Take biopsies of flat area surrounding lesions suspicious for dysplasia
Consider tattoo of suspicious dysplastic lesion arising from flat mucosa or
not able to be completely removed
Take 2 random biopsies in every bowel segment to document microscopic
disease activity
(continued on next page)
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Table 1
(continued)
Biopsies
Circumscribed
lesion
Biopsy of area surrounding lesion; lesions may be removed with
polypectomy or EMR
Targeted and
random
biopsies
Targeted biopsies (can avoid random biopsies) of identified lesions in
good-quality CE
Segmental random biopsies for disease activity documentation
Training
Trainees Gastroenterology fellows and attendings
In-service
training for
nursing staff
Recommended
Trainer Specialized endoscopist: training video is also available from the ASGE
Learning Library to familiarize clinicians with the technique and the
appearance of nonpolypoid colorectal neoplasms
Learning curve Consider transition period of CE with targeted and random biopsy
One study showed that endoscopists were partnered for the first 5 cases,
and that procedure time plateaued at 15 cases
Learning
environment
and resources
Optimal setup of processor, monitor, and cables for optimal imaging
Endoscopy software with image capture
Endoscopy atlas
Training videos
Online resources
Multidisciplinary meetings
Ease of learning
Technical Simple
Image
recognition
Moderate
Quality Measures
Selection of
colitis cases
based on
accepted
surveillance
guidelines
Recommended
Colonoscopy
quality
measures
Recommended, such as bowel preparation quality, cecal intubation rating,
withdrawal times, adenoma detection
Completeness of
procedure
(photographs)
Recommended photographs of terminal ileum, cecum, and any lesion; in
addition, consider segmental photographic documentation even if no
lesion seen
Review of
images
Recommended study of images after examination, as well as after review
of pathology
GI pathologist’s
verification
Recommended
Audit Recommended (concordance with biopsies); additional quality indicators
may include total procedural time, yield of targeted biopsies, volume of
contrast agent
Abbreviations: ASGE, American Society for Gastrointestinal Endoscopy; EMR, endoscopic mucosal
resection; GI, gastrointestinal.
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Leong et al424In our CE implementation study, we assessed the feasibility of learning image inter-
pretation. The 6 endoscopists underwent a short training session that consisted of
viewing a teaching file of images and general instruction on the CE technique. With-
drawal times from the cecum and accuracy of image interpretation were measured.13
Agreement of image interpretation was excellent for both white light and CE. Dysplasia
detection rates were similar to published data from experts.
Procedure Time
The additional procedure time to perform CE is also a potential barrier to implementa-
tion. In a meta-analysis from experienced centers, CE increased procedure time by
11 minutes overall.10 For patients who underwent tandem colonoscopies (the first un-
der white light followed by indigo carmine staining), median extubation times were
11 minutes and 10 minutes respectively.8 In another study, CE increased colonoscopy
time from 35 to 44 minutes overall.14 However, most of the reported times have also
included the time taken for random biopsy. If the practice of random biopsies was
abandoned in favor of targeted biopsies based on enhanced imaging, overall proce-
dure time may be affected little and cost savings may be realized by restricting bi-
opsies to targeted lesions.
In our implementation study, we also observed a learning curve with the technique.
Withdrawal time decreased with experience, ranging from 31 minutes for fewer than 5
procedures to 19 minutes for more than 15 procedures completed.13
SUMMARY
CE with targeted colonic biopsies identifies dysplasia more readily than random bi-
opsies and this evidence-based approach should therefore be adopted into group
and solo practice.1,2,15,16 The technique is easy and requires a low level of equipment.
Mechanisms for its implementation include standardization of protocol and training,
and ensuring quality metrics.
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